jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Pharmacy Practice and Community MedicineNOW IN
Article

Diagnostic Challenges in Metastatic Prostate Adenocarcinoma Using PSMA PET-CT: A Case Report

Bhushan Rane1, Shivani Bedarkar2, Deepak Jha3★, Kishore Wani4★ Corresponding author

  1. 1Department of Pharmaceutics, Shri D. D. Vispute College of Pharmacy and Research Center, Panvel, Maharashtra, INDIA.
  2. 2Department of Medical and Academic Affairs, Kalpene Global Private Limited, Daman, Dadra and Nagar Haveli and Daman and Diu, INDIA.
  3. 3Department of Pharmacy Practice, Sardar Patel College of Pharmacy, Bakrol, Gujarat, INDIA.
  4. 4Department of Urology, Shree Gajanan Maharaj Health Care Private Limited, Nashik, Maharashtra, INDIA.

CORRESPONDENCE

Deepak Jha

Department of Pharmacy Practice, Sardar Patel College of Pharmacy, Bakrol, Gujarat, INDIA.

drdbjmw@gmail.com

Volume 11, Issue 4 · pp. 29–32 · PUBLISHED · DOI: 10.5530/jppcm.20250011

View on JPPCM original site ↗

ABSTRACT

Prostate adenocarcinoma is a common malignancy in elderly males and may present with lower urinary tract symptoms, particularly when advanced or metastatic. We report a 65-year-old male presenting with progressive urinary complaints, chronic low back pain, and generalized weakness. Laboratory evaluation revealed markedly elevated serum prostate-specific antigen levels. Transrectal ultrasound-guided biopsy confirmed prostatic adenocarcinoma with a Gleason score of 4 + 3. Advanced imaging demonstrated metastatic involvement of pelvic lymph nodes and multiple skeletal sites. Prostate-specific membrane antigen positron emission tomography/ computed tomography enabled comprehensive assessment of tumor extent and confirmed disseminated disease. The patient was managed initially with symptomatic therapy and androgen deprivation therapy, followed by bilateral surgical castration after multidisciplinary evaluation. This case highlights the diagnostic challenges associated with advanced prostate carcinoma and emphasizes the clinical value of molecular imaging for accurate staging, prognostication, and therapeutic decision-making. Early recognition and individualized management remain essential to optimize outcomes in metastatic prostate cancer.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Rane, B., Bedarkar, S., Jha, D., & Wani, K. (). Diagnostic Challenges in Metastatic Prostate Adenocarcinoma Using PSMA PET-CT: A Case Report. Journal of Pharmacy Practice and Community Medicine, 11(4), 29–32. https://doi.org/10.5530/jppcm.20250011